These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29432123)

  • 1. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity.
    Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK
    Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of
    Kim M; Seol MH; Lee BC
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catestatin (chromogranin A(352-372)) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling.
    Bandyopadhyay GK; Vu CU; Gentile S; Lee H; Biswas N; Chi NW; O'Connor DT; Mahata SK
    J Biol Chem; 2012 Jun; 287(27):23141-51. PubMed ID: 22535963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.
    Bandyopadhyay GK; Lu M; Avolio E; Siddiqui JA; Gayen JR; Wollam J; Vu CU; Chi NW; O'Connor DT; Mahata SK
    Diabetes; 2015 Jan; 64(1):104-16. PubMed ID: 25048197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
    Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
    Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress:
    Dasgupta A; Bandyopadhyay GK; Ray I; Bandyopadhyay K; Chowdhury N; De RK; Mahata SK
    Comput Struct Biotechnol J; 2020; 18():464-481. PubMed ID: 32180905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catestatin induces glycogenesis by stimulating the phosphoinositide 3-kinase-AKT pathway.
    Bandyopadhyay G; Tang K; Webster NJG; van den Bogaart G; Mahata SK
    Acta Physiol (Oxf); 2022 May; 235(1):e13775. PubMed ID: 34985191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
    Dong B; Zhou Y; Wang W; Scott J; Kim K; Sun Z; Guo Q; Lu Y; Gonzales NM; Wu H; Hartig SM; York RB; Yang F; Moore DD
    Hepatology; 2020 May; 71(5):1559-1574. PubMed ID: 31506976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
    Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.
    Lu M; Patsouris D; Li P; Flores-Riveros J; Frincke JM; Watkins S; Schenk S; Olefsky JM
    Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1036-48. PubMed ID: 20159859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
    Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
    J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.
    Neyrinck AM; Cani PD; Dewulf EM; De Backer F; Bindels LB; Delzenne NM
    Biochem Biophys Res Commun; 2009 Jul; 385(3):351-6. PubMed ID: 19463788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histidine augments the suppression of hepatic glucose production by central insulin action.
    Kimura K; Nakamura Y; Inaba Y; Matsumoto M; Kido Y; Asahara S; Matsuda T; Watanabe H; Maeda A; Inagaki F; Mukai C; Takeda K; Akira S; Ota T; Nakabayashi H; Kaneko S; Kasuga M; Inoue H
    Diabetes; 2013 Jul; 62(7):2266-77. PubMed ID: 23474485
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Na HY; Lee BC
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
    Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
    PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered hepatic glucose homeostasis in AnxA6-KO mice fed a high-fat diet.
    Cairns R; Fischer AW; Blanco-Munoz P; Alvarez-Guaita A; Meneses-Salas E; Egert A; Buechler C; Hoy AJ; Heeren J; Enrich C; Rentero C; Grewal T
    PLoS One; 2018; 13(8):e0201310. PubMed ID: 30110341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel benzenediamine derivative FC98 reduces insulin resistance in high fat diet-induced obese mice by suppression of metaflammation.
    Chen C; Zhang W; Shi H; Zhuo Y; Yang G; Zhang A; Hou Y; Xiang Tan R; Li E
    Eur J Pharmacol; 2015 Aug; 761():298-308. PubMed ID: 26086863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing CB
    Jourdan T; Nicoloro SM; Zhou Z; Shen Y; Liu J; Coffey NJ; Cinar R; Godlewski G; Gao B; Aouadi M; Czech MP; Kunos G
    Mol Metab; 2017 Nov; 6(11):1517-1528. PubMed ID: 29107297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.
    Esser N; Mongovin SM; Mundinger TO; Barrow BM; Zraika S
    Peptides; 2023 Oct; 168():171076. PubMed ID: 37572792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antagonist of CXCR1 and CXCR2 protects
    Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.